Cytosorbents CorporationCTSONASDAQ
Loading
Year-over-year net income growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-3.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -262.81% |
| Q2 2025 | 231.70% |
| Q1 2025 | 81.25% |
| Q4 2024 | -237.77% |
| Q3 2024 | 45.64% |
| Q2 2024 | 29.48% |
| Q1 2024 | 0.75% |
| Q4 2023 | 33.27% |
| Q3 2023 | -49.41% |
| Q2 2023 | 16.01% |
| Q1 2023 | -856.22% |
| Q4 2022 | 93.72% |
| Q3 2022 | -12.15% |
| Q2 2022 | -21.33% |
| Q1 2022 | 3.66% |
| Q4 2021 | -45.28% |
| Q3 2021 | -36.96% |
| Q2 2021 | -12.23% |
| Q1 2021 | -514.97% |
| Q4 2020 | 19.29% |
| Q3 2020 | 70.71% |
| Q2 2020 | 16.97% |
| Q1 2020 | 12.56% |
| Q4 2019 | 42.64% |
| Q3 2019 | -94.11% |
| Q2 2019 | 27.38% |
| Q1 2019 | 9.61% |
| Q4 2018 | -79.80% |
| Q3 2018 | 48.38% |
| Q2 2018 | -95.20% |
| Q1 2018 | 5.24% |
| Q4 2017 | -53.21% |
| Q3 2017 | -84.05% |
| Q2 2017 | 19.01% |
| Q1 2017 | 63.85% |
| Q4 2016 | -42.08% |
| Q3 2016 | 10.72% |
| Q2 2016 | -63.67% |
| Q1 2016 | 8.29% |
| Q4 2015 | 29.68% |